SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-037320
Filing Date
2017-07-19
Accepted
2017-07-19 17:00:26
Documents
3
Period of Report
2017-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v471063_8k.htm 8-K 24258
2 EXHIBIT 99.1 v471063_ex99-1.htm EX-99.1 18187
3 GRAPHIC image_001.jpg GRAPHIC 3252
  Complete submission text file 0001144204-17-037320.txt   48379
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55330 | Film No.: 17972763
SIC: 1000 Metal Mining